IL-8 receptor antagonists

A compound of Formula (I):

• wherein:
• Y is halogen;
• n is 0, 1 or 2;
• X is halogen;
• Ra is selected from the group consisting of hydrogen, C1-4alkyl, C3-6cycloalkyl, C3-6cycloalkylC1-4alkyl, and phenyl, wherein all moieties, except hydrogen, are optionally substituted, one to three times, by halogen, CF3, OH or C1-4alkyl;
• and
• Rb is selected from the group consisting of phenyl, C1-4alkyl, phenylC1-4alkyl, C3-6cycloalkyl, phenylC3-6cycloalkyl and heteroaryl, wherein all moieties are optionally substituted, one to four times, by halogen, CF3 or C1-4alkyl;
• or a pharmaceutically acceptable salt thereof.